SEARCH

SEARCH BY CITATION

  • 1
    Binnie GG: Regression of tumours following treatment by stilboestrol and x-ray therapy, with notes on a case of breast tumour which regressed with stilboestrol alone. Br J Radiol 17: 4245, 1944.
  • 2
    Adair FE, Mellors RC, Farrow JH, et al: The use of estrogens and androgens in advanced mammary cancer: clinical and laboratory study of 105 female patients. JAMA 140: 11931200, 1949.
  • 3
    Kaufman RJ, Rothschild EO, Escher GC, et al: Hypercalcemia in mammary carcinoma following the administration of a progestational agent. J Clin Endocrinol 24: 12351243, 1964.
  • 4
    Kaufman RJ, Escher GC: Rebound regression in advanced mammary carcinoma. Surg Gynecol Obstet 113: 635640, 1961.
  • 5
    Adair FE, Herrmann JB: The use of testosterone propionate in the treatment of advanced carcinoma of the breast. Ann Surg 123: 10231035, 1946.
  • 6
    Cooperative Breast Cancer Group: Testosterone propionate therapy in breast cancer. JAMA 188: 10691072, 1964.
  • 7
    Brodkin RA, Casper MR: Calusterone. Ann Intern Med 89: 945948, 1978.
  • 8
    Gordan GS, Halden A, Walter RM: Antitumor efficacy of 7 β, 17 α-dimethyltestosterone (calusterone) in advanced female breast cancer. Calif Med 113: 110, 1970.
  • 9
    Progress report: results of studies by the Cooperative Breast Cancer Group—1956–1960. Cancer Chemother Rep No 11: 109141, 1961.
  • 10
    Results of studies of the Cooperative Breast Cancer Group—1961–1963. Cancer Chemother Rep No 41 (suppl 1): 124, 1964.
  • 11
    Kaufman RJ, Ochoa M: Combination chemotherapy for hepatic metastases from mammary carcinoma. International Cancer Congress, 11math image, Florence, 1974. Abstracts, vol 3, Milan, Casa Editrice Ambrosione, 1974, pp 599600.
  • 12
    Kaufman RJ: Triple therapy after prophylactic and therapeutic castration failures in patients with mammary carcinoma. Proceedings of the American Association for Cancer Research, abstracted. 17: 297, 1976.
  • 13
    Jonsson U, Colsky J, Lessner HE, et al: Clinical and pharmacological observations of the effects of 9-α-bromo-11-β-ketoprogesterone in patients with carcinoma of the breast. Cancer 12: 509520, 1959.
  • 14
    Ansfield FJ, Davis HL Jr, Ellerby RA, et al: A clinical trial of megestrol acetate in advanced breast cancer. Cancer 33: 907910, 1974.
  • 15
    Pannuti F, Martoni A, Lenaz GR, et al: A possible new approach to the treatment of metastatic breast cancer: massive doses of medroxyprogesterone acetate. Cancer Treat Rep 62: 499504, 1978.
  • 16
    Crowley LG, MacDonald I: Delalutin and estrogens for the treatment of advanced mammary carcinoma in the postmenopausal woman. Cancer 18: 436446, 1965.
  • 17
    Landau RL, Ehrlich EN, Huggins C: Estradiol benzoate and progesterone in advanced human-breast cancer. JAMA 182: 632636, 1962.
  • 18
    Buzdar AU, Tashima CK, Blumenschein GR, et al: Mitomycin C and megestrol acetate in treatment of breast cancer refractory to hormonal and combination chemotherapy. Cancer 41: 392395, 1978.
  • 19
    Segaloff A, Weeth JB, Rongone EL: Hormonal therapy in cancer of the breast. XVI. The effect of δmath image-testololactone on clinical course and hormonal excretion. Cancer 13: 10171020, 1960.
  • 20
    Lemon HM: Prednisone therapy of advanced mammary cancer. Cancer 12: 93107, 1959.
  • 21
    Taylor SG III, Ayer JP, Morris RS Jr: Cortical steroids in the treatment of cancer: observations on effects of pituitary adrenocorticotrophic hormone (ACTH) and cortisone in far advanced cases. JAMA 144: 10581064, 1950.
  • 22
    Witt JA, Gardner B, Gordan GS, et al: Secondary hormonal therapy of disseminated breast cancer. Comparison of hypophysectomy, replacement therapy, estrogens, and androgens. Arch Intern Med 111: 557563, 1963.
  • 23
    Freckman HA, Fry HL, Mendez FL, et al: Chlorambucil-prednisolone therapy for disseminated breast carcinoma. JAMA 189: 2326, 1964.
  • 24
    Greenspan EM: Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma. J Mt Sinai Hosp 333: 127, 1966.
  • 25
    Cooper RG: Combination chemotherapy in hormone resistant breast cancer, abstracted. Proceedings of the American Association for Cancer Research 10: 15, 1969.
  • 26
    Perloff M, Hart RD, Holland JF: Vinblastine, Adriamycin, Thio-tepa, and Halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapy. Cancer 42: 25342537, 1978.
  • 27
    Tormey D, Carbone P, Band P: Breast cancer survival in single and combination chemotherapy trials since 1968, abstracted. Proceedings of the American Association for Cancer Research 18: 64, 1977.
  • 28
    Devitt JE, Advent DA: Effect of current palliative treatment on the survival of patients with breast cancer. Can J Surg 20: 4650, 1977.
  • 29
    Swenerton KD, Legha SS, Smith T, et al: Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 39: 15521562, 1979.
  • 30
    Escher GC, Kaufman RJ: Advanced breast carcinoma-factors influencing survival. Acta Unio Internationalis Contra Cancrum 19: 10391043, 1963.